BRAVE:使HIV-1

Mohammed El Anbari1, Tatsiana Bylund1, Sijy O'Dell1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

概括

一个新的机器学习工具BRAVE准确地预测了人类免疫缺陷病毒-1 (HIV-1) 对广泛中和抗体 (bNAbs) 的耐药性. BRAVE的性能优于现有方法,有助于对HIV-1治疗和预防策略的临床决策.